Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INCYTE CORPORATION

(INCY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
05/15MODERNA  : U.S. CDC Says Administered 270.8 Mln Doses Of COVID-19 Vaccine As Of ..
RE
05/15MODERNA  : U.S. administers 270.8 mln doses of COVID-19 vaccines - CDC
RE
05/14Taiwan tightens curbs after surge in domestic COVID-19 cases
RE
05/14MCDONALD'S, TESLA, DISNEY : Stocks That Defined the Week
DJ
05/14DGAP-PVR  : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
DJ
05/14DGAP-DD  : QIAGEN N.V. english
DJ
05/14Why the CDC Told Fully Vaccinated Americans They Didn't Need to Wear Face Mas..
DJ
05/14MODERNA  : COVID SCIENCE-Delayed 2nd Pfizer/BioNTech shot boosts antibodies in e..
RE
05/14MODERNA  : U.S. administers 268.4 mln doses of COVID-19 vaccines - CDC
RE
05/14MODERNA  : U.S. CDC Says Delivered 341.9 Million Doses Of Covid-19 Vaccine As Of..
RE
05/14ABCELLERA BIOLOGICS  : Credit Suisse Lowers AbCellera Biologics' PT to $51 from ..
MT
05/14IONIS PHARMACEUTICALS  : SVB Leerink Adjusts Ionis Pharmaceuticals' Price Target..
MT
05/14FATE THERAPEUTICS  : Wedbush Adjusts Price Target on Fate Therapeutics to $71 Fr..
MT
05/14CHARLES RIVER LABORATORIES INTERNATI : KeyBanc Adjusts Price Target on Charles R..
MT
05/14IQVIA  : KeyBanc Adjusts IQVIA Holdings' Price Target to $260 From $255, Keeps O..
MT
05/14Parents Rush to Get Covid-19 Vaccines for Their Children
DJ
05/14Samsung Biologics Rallies on Possible Moderna Covid-19 Vaccine Deal
DJ
05/13Samsung BioLogics says decision pending on making Moderna vaccine as report i..
RE
05/13SAMSUNG BIOLOGICS  : says no decision yet on producing Moderna's COVID-19 shot
RE
05/13MODERNA  : U.S. administers 266.6 mln doses of COVID-19 vaccines - CDC
RE
05/13MODERNA  : Vaccine waiver talks a chance for WTO to show its relevance -U.S. tra..
RE
05/13GLAXOSMITHKLINE  : CureVac-GSK coronavirus variant vaccine generates good immune..
RE
05/13PRESS RELEASE  : CureVac : Second-Generation -2-
DJ
05/13PRESS RELEASE  : CureVac : Second-Generation COVID-19 Vaccine Candidate, CV2CoV,..
DJ
05/13TODAY'S ANALYST RECOMMENDATIONS : Alibaba, BioNTech, Home Depot, Lowe's, Roblox...
05/13LONZA  : AlphaValue/Baader Europe Lowers Price Target on Lonza Group
MT
05/13Surgeon General, Artists, CEOs at WSJ's Future of Everything Festival
DJ
05/13MODERNA  : Second S.Korea expert panel backs approval of Moderna vaccine
RE
05/12Australia seeks deal with Moderna for domestic production of mRNA vaccines
RE
05/12MODERNA  : Australia in 'active talks' with Moderna to locally produce mRNA vacc..
RE
05/12MODERNA  : COVID SCIENCE-mRNA vaccines appear effective vs India variant; people..
RE
05/12CDC Panel Recommends Pfizer-BioNTech Covid-19 Vaccine for 12- to 15-Year-Olds..
DJ
05/12MODERNA  : U.S. administers nearly 264.7 mln doses of COVID-19 vaccines - CDC
RE
05/12CDC Panel Recommends Pfizer-BioNTech Covid-19 Vaccine for 12- to 15-Year-Olds..
DJ
05/12MODERNA  : U.S. CDC Says Delivered 337,089,765 Doses Of COVID-19 Vaccine As Of M..
RE
05/12CDC Panel Recommends Pfizer-BioNTech Covid-19 Vaccine for 12- to 15-Year-Olds..
DJ
05/12CDC Panel Recommends Pfizer-BioNTech Covid-19 Vaccine for 12- to 15-Year-Olds
DJ
05/12CDC Panel Considers Covid-19 Vaccine for 12-to-15-Year-Olds -- 2nd Update
DJ
05/12ASTRAZENECA  : Norway drops AstraZeneca vaccine, J&J remains on hold
RE
05/12MODERNA  : U.S. CDC identifies 28 clotting cases after J&J vaccine
RE
05/12BIONTECH  : Canaccord Genuity Adjusts Price Target on BioNTech to $240 From $130..
MT
05/12IQVIA  : Argus Adjusts IQVIA Holdings' Price Target to $260 From $220, Keeps Buy..
MT
05/12VERTEX PHARMACEUTICALS  : UBS Adjusts Price Target on Vertex Pharmaceuticals to ..
MT
05/12CDC Panel Considers Covid-19 Vaccine for 12-to-15-Year-Olds -- Update
DJ
05/12NOVAVAX  : B. Riley Lowers Novavax' Price Target to $286 from $365, Notes Weaken..
MT
05/12NOVAVAX  : Cantor Fitzgerald Adjusts Price Target on Novavax to $217 From $338, ..
MT
05/12EXACT SCIENCES  : Truist Securities Adjusts Exact Sciences' Price Target to $168..
MT
05/12EVOTEC  : Deutsche Bank sticks Neutral
MD
05/12NOVAVAX  : HC Wainwright Adjusts Price Target on Novavax to $294 From $317, Main..
MT
05/12NOVAVAX  : JPMorgan Cuts Novavax to Neutral From Overweight, Price Target to $16..
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
05/04Press Release 
05/041st quarter results 
05/04SEC Filing 10Q-1 
05/04SEC Filing 8K 
04/23Report 
04/09Report 
Upcoming event on INCYTE CORPORATION